Does SILTUXIMAB Cause Off label use? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Off label use have been filed in association with SILTUXIMAB (Sylvant). This represents 20.3% of all adverse event reports for SILTUXIMAB.
96
Reports of Off label use with SILTUXIMAB
20.3%
of all SILTUXIMAB reports
27
Deaths
27
Hospitalizations
How Dangerous Is Off label use From SILTUXIMAB?
Of the 96 reports, 27 (28.1%) resulted in death, 27 (28.1%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SILTUXIMAB. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does SILTUXIMAB Cause?
Drug ineffective (72)
Disease progression (32)
Immune effector cell-associated neurotoxicity syndrome (28)
Death (27)
Cytokine release syndrome (26)
Hypertension (24)
Product use in unapproved indication (24)
Drug effective for unapproved indication (23)
Cataract (19)
Condition aggravated (19)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SILTUXIMAB Alternatives Have Lower Off label use Risk?
SILTUXIMAB vs SILVER SULFADIAZINE
SILTUXIMAB vs SIMEPREVIR
SILTUXIMAB vs SIMPONI
SILTUXIMAB vs SIMVASTATIN
SILTUXIMAB vs SINGULAIR